Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301235 · ClinicalTrials.gov registry record
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 8
- Enrollment target
NCT01301235: Completed study, sponsored by Massachusetts General Hospital.
NCT01301235 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01301235 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This is a developmental protocol to determine the MRI based 31P-MRS changes seen in subjects with mitochondrial myopathy using our dynamic exercise protocol and to identify the ideal variable(s) to represent mitochondrial function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-04 |
What the finished NCT01301235 record still lists
NCT01301235 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01301235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01301235 about?
NCT01301235 is a clinical study titled "Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy". This is a developmental protocol to determine the MRI based 31P-MRS changes seen in subjects with mitochondrial myopathy using our dynamic exercise protocol and to identify the ideal variable(s) to represent mitochondrial function.
What is the current status of trial NCT01301235?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2011-02. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01301235?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia